Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 3/20 | 0.45 |
| ▸ | CDK4 | P11802 | 6/20 | 0.45 |
| ▸ | CCND1 | P24385 | 6/20 | 0.45 |
| ▸ | CCND2 | P30279 | 6/20 | 0.45 |
| ▸ | CCND3 | P30281 | 6/20 | 0.45 |
| ▸ | JAK3 | P52333 | 4/20 | 0.42 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.41 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.41 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.41 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.41 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.41 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.41 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16286127 | 0.92 | CDK4 (0.42) | BRD4CDK4CCND1CCND2CCND3 | |
| SCHEMBL16285677 | 0.90 | JAK2 (0.49) | BRD4CDK4CCND1CCND2CCND3 | |
| SCHEMBL16285706 | 0.88 | CDK4 (0.48) | BRD4CDK4CCND1CCND2CCND3 | |
| SCHEMBL16286122 | 0.87 | FGFR4 (0.44) | CDK4CCND1CCND2CCND3JAK3 | |
| SCHEMBL16285672 | 0.85 | CCND3 (0.47) | CDK4CCND1CCND2CCND3JAK3 | |
| SCHEMBL16285699 | 0.84 | CDK4 (0.46) | CDK4CCND1CCND2CCND3JAK3 | |
| SCHEMBL16285692 | 0.84 | CDK4 (0.46) | CDK4CCND1CCND2CCND3FGFR1 | |
| SCHEMBL16285713 | 0.84 | CDK4 (0.46) | CDK4CCND1CCND2CCND3JAK3 | |
| SCHEMBL16285685 | 0.83 | FYN (0.47) | CDK4CCND1CCND2CCND3JAK3 | |
| SCHEMBL10192715 | 0.82 | CDK4 (0.67) | CDK4CCND1CCND2CCND3JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140364430-A1 | METHODS FOR TREATING SCHIZOPHRENIA | AFRAXIS HOLDINGS INC (US) | 2014-12-11 | — | — | US | disclosed |
| US-20140364430-A1 | METHODS FOR TREATING SCHIZOPHRENIA | AFRAXIS HOLDINGS INC (US) | 2014-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364430-A1 | METHODS FOR TREATING SCHIZOPHRENIA | GRIN2A, GRIN2C, GRIN3A | BRD4 469/4885CDK4 2824/4885CCND1 4822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.